Leishmaniasis in Childhood;Leishmaniasis en la Infancia

Medicina Cutanea Ibero-Latino-Americana

Volumn 31, Issue 6, 2003, Pages 351-361

  Castro Grüber, Solange ^a   Zerpa Rangel, Olga ^a   Rondón Lugo, Antonio ^a  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

Author keywords

Childhood; Leishmaniasis; Miltefosine

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; ANTILEISHMANIAL AGENT; ANTIMONY DERIVATIVE; BCG VACCINE; IMMUNOMODULATING AGENT; ITRACONAZOLE; KETOCONAZOLE; LEISHMANIA VACCINE; MEGLUMINE ANTIMONATE; MILTEFOSINE; PAROMOMYCIN; PENTAMIDINE; STIBOGLUCONATE SODIUM; TERBINAFINE;

ALBANIA; BRAZIL; CHILDHOOD DISEASE; CONVULSION; DIARRHEA; FEVER; GASTROINTESTINAL SYMPTOM; GEOGRAPHIC DISTRIBUTION; HEADACHE; HUMAN; IMMUNOTHERAPY; INJECTION PAIN; IRON DEFICIENCY ANEMIA; LEISHMANIA; LEISHMANIASIS; MALAISE; MYALGIA; NAUSEA; OPPORTUNISTIC INFECTION; PHLEBITIS; REVIEW; SERODIAGNOSIS; SKIN LEISHMANIASIS; SOUTHERN EUROPE; UREMIA; VENEZUELA; VISCERAL LEISHMANIASIS; VOMITING;

EID: 1942475776     PISSN: 02105187     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Desjeux P. Leishmaniasis Public Health Aspects and Control. Clin Dermatol 1996; 14: 417-23.
2. Desjeux P. Programme for the surveillance and control of leishmaniasis 1999. World Health Organization Department of Communicable Disease Surveillance and Response (CSR). 1999 (fecha de acceso 20 de agosto 2003). Disponible en: http://www.who.int/emc/diseases/leish/index.html.
3. Arias J, Beltrán F, Desjeux P, Walton B. Epidemiología y control de la leishmaniasis en las Américas, por país o territorio. Oficina sanitaria Panamericana. Washington, D.C.: OPS, 1996. Cuaderno Tecnico n° 44, ix, p 52.
4. Vélez I, Hendrickx E, Robledo S, Agudelo S. Gender and cutaneous leishmaniasis in Colombia. Cad. Saúde Pública, Rio de Janeiro 2001; 17: 171-80.
5. Zare S, Baghestani S. Cutaneous leishmaniasis in Hormozgan, Iran. Int J Dermatol 2001; 40: 629-31.
6. De Castro EA, Soccol VT, Membrive N, Luz E. Epidemiological and clinical study of 332 cases of cutaneous leishmaniasis in the north of Parana State from 1993 to 1998. Rev Soc Bras Med Trop 2002; 35: 445-52.
7. Bittencourt A, Barral A, Costa J. Tegumentary leishmaniasis in childhood. Pediatr Dermatol 1996; 13: 455-63.
8. Kafetzis DA. An Overview of Paediatric Leishmaniasis. J Postgrad Med 2003; 49: 31-8.
9. Estadísticas del Departamento de Informática del Servicio Central de Dermatología Sanitaria del Ministerio de Salud y Desarrollo Social de Venezuela.
10. Zerpa O, Ulrich M, Borges R, Rodríguez V, Centeno M, Negrón E et al. Epidemiological aspects of human and canine visceral leishmaniasis in Venezuela. Rev Pan Am Sal Pub 2003; 13.
11. Lito G, Davachi F, Sulcebe G, Bregu H, Basha M. Pediatric visceral leishmaniasis in Albania. Int J Infect: Dis 2002; 6: 66-8.
12. Marty P, Leger I, Albertiri M et al. La leishmaniose viscérale infantile dans les Alpes Maritimes de 1985 a 1992. Bull Soc Pathol Exot 1994; 87: 105-9.
13. Manual de control, diagnóstico y tratamiento de Leishmaniasis Visceral (Calazar). Normas técnicas. Ministerio de salud de Brasil. 1994. p12.
14. Leishmaniasis and Leishmania/HIV coinfection in: Communicable Disease Surveillance and Response 2001. WHO Report on Global Surveillance of Epidemicprone Infection Diseases Disponible en: http://www.who.int/emc-documents/ surveillance/docs/whocdscsrisr2001.html/ Leishmaniasis/Leishmaniasis.htm.
15. Grimaldi GJR, Tesh RB, McMahon-Pratt D. A review of the geographic distribution and epidemiology of leishmaniasis in the new world. Am J Trop Med Hyg 1989; 41: 687-725.
16. Rodríguez N, Guzman B, Rodas A, Takiff H, Bloom BR and Convit J. Diagnosis of Cutaneous Leishmaniasis and Species Discrimination of Parasites by PCR and Hybridization. J Clin Microbiol 1994: 2246-52.
17. Alvar EJ. "El Protozoo" Las Leishmaniasis de la Biología al Control. Junta de Castilla de León 1997: 17-31.
18. Killick-Kendrick R, Wilkes TJ, Bailly M, Bailly I and Righton LA. Preliminary Field Observations on the Flight Speed of a Phebotomine Sandfly. Trans R Soc Trop Med Hyg 1986; 80: 138-42.
19. Furtado T. Criterios para o Diagnóstico da Leishmaniose Tegumentar Americana. An Bras Dermatol 1980; 55: 81-6.
20. OMS. "Control of the Leishmaniasis". Technical Report Series 793. Geneva 1990: 25.
21. De Lima H; Rodriguez N; De Guglielmo Z; Rodriguez A ans Convit J. "Cotton Rats and Black Rats as Possible Reservoirs of Cutaneous Leishmaniasis in an Endemic area in Lara State, Venezuela". En Prensa.
22. Convit J and Pinardi ME. "Cutaneous Leishmaniasis The Clinical and Inmunopathological Spectrum in South America". Published (1974) by ASP (Elsevier-Excerpta Medica-North Holland), Amsterdam p. 160-6.
23. Convit J, Ulrich M, Fernández CT, Tapia FJ, Cá ceres-Dittmar G, Castés M and Rondón AJ. The Clinical and Inmunological Spectrum of American Cutaneous Leishmaniasis. Trans R Soc Trop Med Hyg 1993; 87: 444-8.
24. Dowlati Y. Cutaneous Leishmaniasis: clinical aspects. Clin Dermatol 1996; 14: 425-31.
25. Rondón Lugo AJ. Leishmaniasis tegumentaria americana. Clin Dermatol Venez 1993; 31: 12-17.
26. Bray RS, Lainson R. The Immunology and Serology of Leishmaniasis the Fluorescent Antibody Staining Technique. Trans R Soc Trop Med Hyg 1965; 59: 535-44.
27. Al-Gindan Y, Kubba R, El-Hasssan AM. Dissemination in cutaneuos leishmaniasis.3. Lymph node involvement. Int J Dermatol 1989; 28: 248-539.
28. Reyes Flores O. Histopatología de la Leishmaniasis. Derm Ven 1993; 31: 22-3.
29. Ridley DS, Marsden PD, Cuba CC and Barreto AC. A Histological Classification of Mucocutaneous Leishmaniasis in Brazil and Its Clinical Evaluation. Trans R Soc Trop Med Hyg 1980; 74: 508.
30. Castés M y Tapia FJ. Inmunopatología de la Leishmaniasis Tegumentaria Americana. Acta Científica Venezolana 1998; 49: 42-56.
31. Tapia FJ, Cáceres-Dittmar G, Sánchez MA, Fernández CT, Rondón AJ and Convit J. Adhesion Molecules in Lesions of American Cutaneous Leishmaniasis. Exp Dermatol 1994; 3: 17-22.
32. Díaz N.L, Zerpa O, Ponce L, Convit J, Rondón A, Tapia F. Intermediate or chronic cutaneous leishmaniasis: Leukocyte immunophenotypes and cytokine characterisation of the lesion. Exp Dermatol 2002; 11: 34-41.
33. Zerpa O, Convit J, Tapia J, Díaz N, Ponce L. Inmunocitos y citocinas en el espectro intermedio de la leishmaniasis cutánea. Libro de resúmenes de la XXXVI Reunión anual de la Sociedad Venezolana de Dematología y Cirugía Dermatológica; 2000 Nov 09-11; Maracaibo, Venezuela p 11.
34. Convit J, Lapenta P. Sobre un Caso de Leishmaniasis Tegumentaria de Forma Diseminada. Rev Policlínica Caracas 1948; 17: 153-8.
35. Franke E, Lucas C, Tovar A, Kruger J.H, Seminario V, Wignall F.S. Diffuse cutaneous Leishmaniasis acquired in Peru. Am J Trop Med Hyg 1990; 43: 260-2.
36. Bryceson A.D.M. Diffuse cutaneous Leishmaniasis in Ethipoia. I. The clinical and histological features of the disease. Trans R Soc Trop Med Hyg 1969; 63: 708.
37. Convit J, Pinardi M, Rondón A. Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host. Trans R Soc Trop Med Hyg 1972; 66: 603-10.
38. Cáceres-Dittmar G, Tapia FJ, Sánchez, M, Yamamura K, Uyemura, RL, Modlin RL et al. De-termination of the cytokine profile in American cutaneous leishmaniasis usin the polymerase chain reaction. Clin Exp Immunol 1993; 91: 500-5.
39. Cáceres-Dittmar G; Sánchez MA, Rondón AJ, Tapia FJ. Immunocytochemical characterization of epidermal cells in American cutaneous leishmaniasis. Acta Micros 1995 b; 1: 118-21.
40. Tapia FJ, Cáceres-Dittmar G, Sánchez MA. Epidermal immune privilege in American cutaneous leishmaniasis. In: "Molecular and immune mechanisms in the pathogenesis of cutaneous leishmaniasis". Tapia FJ, Cáceres-Dittmar G, Sánchez MA editores. RG. Landes Co. Bioscience Publishers, Austin, Texas, 1996, p 139-52.
41. Marsden PD. Mucosal Leishmaniasis ("Espudia" Escomel, 1911). Trans R Soc Trop Med Hyg 1986; 80: 859-76.
42. El-Hassan AM, Meredith SEO, Yagi HI, Khalil EAG, Ghalib HW, Abbs K et al. Sudanese Mucosal Leishmaniasis: Epidemiology, Clinical Features, Diagnosis, Immune Responses and Treatment. Trans R Soc Trop Med Hyg 1995; 89: 647-52.
43. Marsden PD and Nonata RH. Mucocutaneous Leishmaniasis: A Review of Clinical Aspects. Rev Soc Bras Med Trop 1975; 6: 325-6.
44. Rondón AJ. "Leishmaniasis Tegumentaria Americana". Dermatología Rondón Lugo, Reinaldo Godoy Editor (1995) Tomo I p537-547.
45. Ulrich M. La Respuesta Humoral en Leishmaniasis Americana. Derm Ven 1993; 31: 31-3.
46. Sánchez M, Cáceres-Dittmar G, Oriol O. Epidermal Langerhans Cells Dendritic Epidermal T Cells in Murine Cutaneos Leishmaniasis Immunocytochemical Study. Acta Microsc 1993; 2: 180-7.
47. Lewis RE, Buchsbaum M, Whitaker D, Murphy GF. Intercellular adhesion molecule expression in the evolving human cutaneous delayed hypersensitivity reaction. J Invest Dermatol 1989; 93: 672-7.
48. Rondón A, Zerpa O, Capozzi E. "Leishmaniasis cutáneo-mucosa". En: Iturriaga E, Torres JR, Ríos A editores. Enfermedades tropicales en otorrinolaringología. Venezuela. Publigráfica 66 c.a.; 2001, p39-56.
49. Guarneri C, Vaccaro M, Cannavo SP, Borgia F, Guarneri B. Erythematous-edematous-infiltrative plaque on the face: cutaneous angio-lupoid leishmaniasis. Eur J Dermatol 2002; 12: 597-9.
50. Weigle KA, De Davalos M, Heredia P, Molineros R, Saravia NG and D' Alessandro A. Diagnosis of Cutaneous and Mucocutaneous Leishmaniasis in Colombia: A Comparasion of Seven Methods. Am J Trop Med. Hyg 1987; 36: 489-96.
51. Reed PhD SG. Diagnosis of Leishmaniasis. Clin Dermatol 1996; 14; 5: 471-8.
52. Cuba CA, Marsden P, Barreto AC, Rocha R, Sampaio RR, Patzlaff L. Diagnóstico Parasitológico e Inmunológico de Leishmaniasis Tegumentaria Americana. Bol of Sanit Panam 1980; 89: 195-206.
53. López M, Inga R, Cangalaya M, Echevarria J, Llanos Cuentas A, Orrego C, Arevalo J. Diagnosis of Leishmanina Using The Polymerase Chain Reaction: A Simplified Procedure for Field Work. Am J Trop Med. Hyg 1993; 49: 34-42.
54. Ulrich M, Rodriguez V, Centeno M. Differing Antibody IgG Isotypes in The Polar Forms of Leprosy and Cutaneous Leishmaniasis Characterized By Antigen Specific T Cell Anergy. Clin Exp Immunol 1995; 100: 54-8.
55. Restrepo Isaza M. La Reación de Montenegro en la Epidemiología de la Leishmaniasis Sudamericana. Bol of Sanit Panam 1980; 89: 130.
56. Tracy JW, Webster Jr LT. Fármacos usados en la quimioterapia de las infecciones causadas por protozoos. Cap 41. En: Hardman J, Limbird L, Morlinoff P, Ruddon R, Goodman Gilman A (editores). Goodman y Gilman. Las bases farmacológicas de la terapéutica. Nov Ed. Vol II. México. MacGraw-Hill Interamericana; 2001 p 1062-5.
57. Berman JD. Treatment of New World Cutaneous and Mucosal Leishmaniasis. Clin Dermatol 1996; 14: 519-22.
58. Sampaio RNR, Sampaio JHD, Marsden PD. Pentavalent Antimonial Treatment in Mucosal Leishmaniasis. The Lancet. 1985: 1097.
59. Marsden PD, Raimunda N, Sampaio R, Carvalho EM, Veiga J, Costa J et al. High Continuous Antimony Therapy in Two Patients With Unresponsive Mucosal Leishmaniasis. Am J Trop Med Hyg 1985; 34: 710-3.
60. Franke PhD ED, Wignall FS, Cruz ME, Rosales E, Tovar A, Lucas C et al. Efficacy and Toxicity of Sodium Stibogluconate for Mucosal Leishmaniasis. Annals of Internal Medicine 1990; 113: 12: 934.
61. Veiga JPR, Wolff ER, Sampio RN. Renal Tubular Dysfuction in Patients With Mucocutaneous Leishmaniasis Treated With Pentavalent Antimonials. Lancet 1983; 2: 569.
62. Gaeta GB, Maisto A, Di Caprio D, Scalone A, Pasquale G, Felaco FM, et al. Efficacy of amphotericin-B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent patients. Scand J Infect Dis 2000; 32: 675-7.
63. Sundar S, Agrawal G, Rai M, Makharia MK, Murray HW. Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin-B: randomized trial. BMJ 2001; 323: 419-22.
64. Soto J, Buffet P, Grogl M. Successful Treatment of Colombian Cutaneous Leishmaniasis With 4 Injections of Pentamidine. Am J Trop Med Hyg 1994; 50: 107-11.
65. Becker I, Volkow P, Velasco-Castrejon O, Salaiza-Suazo N, Berzunza-Cruz M, Domínguez JS et al. The efficacy of pentamidine combined with allopurinol and immunotherapy for the treatment of patients with diffusse cutaneous leishmaniasis. Parasitol Res 1999; 85: 165-70.
66. Fischer C, Voss A, Engel J. Development status of miltefosine as first oral drug in visceral and cutaneous leishmaniasis. Med Microbiol Immunol (Berl) 2001; 190: 85-7.
67. Soto J, Toledo J, Gutierrez P, Nicholls R.S, Padilla J, Engel J et al. Treatment of American Cutaneous Leishmaniasis with Miltefosine, an Oral Agent. Clin Infect 2001; 33: 57-61.
68. Convit J, Castellanos PL, Rondón AJ, Pinardi ME, Ulrich M, Castés M, et al. Immunotherapy Versus Chemotherapy in Localized Cutaneous Leishmaniasis. Lancet 1987; 1: 401-5.
69. Convit J. Leishmaniasis Inmunological and Clinical Aspects and Vaccines in Venezuela. Clin Dermatol 1996; 14: 479-87.
70. Convit J, Ulrich M, Castellano P, Castés M, Pinardi ME, De Lima H et al. Desarrollo de Inmunoterapia de la Leishmaniasis Cutánea Americana en el Instituto de Biomedicina. Gaceta Médica Caracas 1996; 104: 232-46.
71. Convit J, Castellanos PL, Rondón A. Inmunotherapy of Localized, Intermediate, and Diffuse forms of American Cutaneous Leishmaniasis. J Infect Dis 1989; 160: 104-15.
72. Murray HW. Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob Agents Chemother 2001; 45: 2185-97.
73. Da Matta VL, Hoshino-Shimizu S, Dietze R, Corbett CE. Detection of specific antibody isotypes and subtypes before and after treatment of American visceral leishmaniasis. J Clin Lab Anal 2000; 14: 5-12.
74. Teklemariam S, Hiwot AG, Frommel D, Miko TL, Ganlov G, Bryceson A. Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopica. Trans R Soc Trop Med Hyg 1994; 88: 334-9.
75. Kumar V, Agrawal S, Rani S, Joshi A, Agarwalla A, Lal das M et al. Post-kalaazar dermal leishmaniasis in Nepal. Int J Dermatol 2001; 40: 179-84.
76. Musa AM, Khalil EA, Raheem MA, Zijlstra EE, Ibrahim ME, Munkhtar MM et al. The natural history of Sudanese post-kalazar dermal leishmaniasis: clinical, immunological and prognostic features. Ann Trop Med Parasitol 2002; 96: 765-72.